The short version of clinical endpoint fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-16. Anything still debated is marked as such rather than presented as settled.
Thymosin alpha 1 is a 28-amino-acid peptide first isolated from thymosin fraction 5, a bovine thymic extract. Its sequence begins with an acetylated serine residue and carries a high proportion of acidic residues, so the molecule has a net negative charge near neutral pH. Despite the shared name, it is unrelated in sequence to the thymosin beta family. Synthetic material prepared by solid-phase peptide synthesis is identical in sequence to the natural peptide.
Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C129H215N33O55 | Calculated for the acetylated 28-residue peptide |
| Appearance | White to off-white powder | Lyophilized solid recovered from aqueous buffer |
| Solubility | Freely soluble in water | Typically dissolved in water or buffer before use |
| Typical storage | -20 C or below, desiccated | Protect from light and avoid repeated freeze-thaw cycles |
| Identity testing | Reverse-phase HPLC with mass spectrometry | Retention time and measured mass confirm the sequence |
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
==== Ion exchange chromatography ==== Ion exchange chromatography is often employed in the first step, or capturing step, for the separation of PEGylated proteins as PEGylation may affect the charges of target proteins by neutralizing electrostatic interaction, changing the isoelectric point (pI), and increasing the pKa value. Due to the high pI of lysozyme (pI = 10.7), cation exchange chromatography is used. As the increased degree of PEGylation decreases the ion strength of the protein, the poly-PEGylated proteins tend to bind to the cation resin weaker than the mono-PEGylated protein or the intact form does. Thus, the poly-PEGylated proteins elute faster and the intact protein eludes last in the cation exchange chromatography. As mono-PEGylated is widely investigated and described as a protection of target proteins, the target eluate in the cation exchange chromatography is usually the mono-PEGylated proteins.
=== Scientific analyses === Cultural considerations can sometimes interfere with the conservation of human remains, particularly when it comes to physical and chemical analyses, which play an important role in their care. Testing conducted on human remains, especially ancient ones, can include DNA testing, isotope analyses, and carbon-14 dating. The benefits of such testing is sometimes outweighed by the cultural or sacred importance of the remains as well as the risk of damaging them too greatly. According to the Deutscher Museumsbund, there are only three circumstances in which scientific research should be conducted on human remains:
After pressure from the Department of Justice and after more than 1,000 churches said they would reopen, Newsom announced that churches would be allowed to open at 25% capacity. On April 9, 2021, the Supreme Court ruled against Newsom for a fifth and final time regarding his prohibitions and limits on religious gatherings. In a 5-4 decision, the court ruled that California unfairly singled out religious gatherings for restrictions and struck down the remaining restrictions on at-home religious gatherings. As the state opened up, the Los Angeles Times found that new coronavirus hospitalizations in California began accelerating around June 15 at a rate not seen since early April, immediately after the virus began rapidly spreading in the state. On June 18, Newsom made face coverings mandatory for all Californians in an effort to reduce COVID-19's spread. Enforcement was up to business owners, as local law enforcement agencies saw non-compliance as a minor infraction. By the end of June, Newsom had ordered seven counties to close bars and nightspots and recommended that eight other counties take action on their own to close those businesses due to a surge of coronavirus cases in parts of the state. In a regular press conference on July 13 as he was ordering the reinstatement of the shutdown of bars and indoor dining in restaurants, he said, "We're seeing an increase in the spread of the virus, so that's why it's incumbent upon all of us to recognize soberly that COVID-19 is not going away any time soon until there is a vaccine or an effective therapy".
Sources: en.wikipedia.org
Metals can be used to assemble a variety of useful products, including sealed containers (such as tanks and pipes), mirrors for focusing sunlight, and thermal radiators. The use of metals for electrical devices would require insulators for the wires, so a flexible insulating material such as plastic or fiberglass will be needed. A notable output of space manufacturing is expected to be solar panels. Expansive solar energy arrays can be constructed and assembled in space. As the structure does not need to support the loads that would be experienced on Earth, huge arrays can be assembled out of proportionately smaller amounts of material. The generated energy can then be used to power manufacturing facilities, habitats, spacecraft, lunar bases, and even beamed down to collectors on the Earth with microwaves. Other possibilities for space manufacturing include propellants for spacecraft, some repair parts for spacecraft and space habitats, and, of course, larger factories. Ultimately, space manufacturing facilities can hypothetically become nearly self-sustaining, requiring only minimal imports from the Earth. The microgravity environment allows for new possibilities in construction on a massive scale, including megascale engineering. These future projects might potentially assemble space elevators, massive solar array farms, very high capacity spacecraft, and rotating habitats capable of sustaining populations of tens of thousands of people in Earth-like conditions.
=== Small revival === The current chairman of the party is Klaus Brall. The party is affiliated with the European Christian Political Party. In 2022, former Alternative for Germany member Uwe Witt joined the party while still holding his seat in the Bundestag. It is the first time since 1957 that the party has held a seat in the Bundestag. Witt subsequently left in August of the same year. The party also got its first representation in the European Parliament on 10 June 2022, when the former AfD co-chairman Jörg Meuthen joined the party. However, Meuthen left the party in September 2023.
Immersion in warm water or sour milk, followed by the application of snake-stones (also known as la Pierre Noire), which are believed to draw off the poison in much the way a sponge soaks up water. Application of a one-percent solution of potassium permanganate or chromic acid to the cut, exposed area. The latter substance is notably toxic and carcinogenic. Drinking abundant quantities of alcohol following the cauterization or disinfection of the wound area. Use of electroshock therapy in animal tests has shown this treatment to be useless and potentially dangerous. In extreme cases, in remote areas, all of these misguided attempts at treatment have resulted in injuries far worse than an otherwise mild to moderate snakebite. In worst-case scenarios, thoroughly constricting tourniquets have been applied to bitten limbs, completely shutting off blood flow to the area. By the time the person finally reached appropriate medical facilities, their limbs had to be amputated.
== External links == Glucagon-Like Peptide-2 Receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Sources: en.wikipedia.org
It is a 28-amino-acid peptide originally purified from a bovine thymic extract and later produced synthetically. It is studied mainly for its effects on immune cell function.
No. The two peptides share part of a name but differ in length, sequence, and net charge. Literature searches that treat them as one compound return misleading results.
Solid-phase peptide synthesis is the usual route, and recombinant expression has also been described. Both approaches produce material matching the natural sequence.
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.